BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 18332680)

  • 1. Effects of SB-269970, a 5-HT7 receptor antagonist, in mouse models predictive of antipsychotic-like activity.
    Galici R; Boggs JD; Miller KL; Bonaventure P; Atack JR
    Behav Pharmacol; 2008 Mar; 19(2):153-9. PubMed ID: 18332680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spinal 5-HT7 receptors are critical for alternating activity during locomotion: in vitro neonatal and in vivo adult studies using 5-HT7 receptor knockout mice.
    Liu J; Akay T; Hedlund PB; Pearson KG; Jordan LM
    J Neurophysiol; 2009 Jul; 102(1):337-48. PubMed ID: 19458153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antipsychotic-like properties of phosphodiesterase 4 inhibitors: evaluation of 4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone (RO-20-1724) with auditory event-related potentials and prepulse inhibition of startle.
    Halene TB; Siegel SJ
    J Pharmacol Exp Ther; 2008 Jul; 326(1):230-9. PubMed ID: 18420599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective blockade of 5-hydroxytryptamine (5-HT)7 receptors enhances 5-HT transmission, antidepressant-like behavior, and rapid eye movement sleep suppression induced by citalopram in rodents.
    Bonaventure P; Kelly L; Aluisio L; Shelton J; Lord B; Galici R; Miller K; Atack J; Lovenberg TW; Dugovic C
    J Pharmacol Exp Ther; 2007 May; 321(2):690-8. PubMed ID: 17314195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine D2S and D2L receptors may differentially contribute to the actions of antipsychotic and psychotic agents in mice.
    Xu R; Hranilovic D; Fetsko LA; Bucan M; Wang Y
    Mol Psychiatry; 2002; 7(10):1075-82. PubMed ID: 12476322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amphetamine-induced disruption of prepulse inhibition in mice with reduced NMDA receptor function.
    Moy SS; Perez A; Koller BH; Duncan GE
    Brain Res; 2006 May; 1089(1):186-94. PubMed ID: 16638606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-HT7 receptor inhibition and inactivation induce antidepressantlike behavior and sleep pattern.
    Hedlund PB; Huitron-Resendiz S; Henriksen SJ; Sutcliffe JG
    Biol Psychiatry; 2005 Nov; 58(10):831-7. PubMed ID: 16018977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of the selective 5-HT7 receptor antagonist SB 269970 in animal models of anxiety and depression.
    Wesołowska A; Nikiforuk A; Stachowicz K; Tatarczyńska E
    Neuropharmacology; 2006 Sep; 51(3):578-86. PubMed ID: 16828124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Further neurochemical and behavioural investigation of Brattleboro rats as a putative model of schizophrenia.
    Cilia J; Gartlon JE; Shilliam C; Dawson LA; Moore SH; Jones DN
    J Psychopharmacol; 2010 Mar; 24(3):407-19. PubMed ID: 19204063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. WAY-163909 [(7bR,10aR)-1,2,3,4,8,9,10,10a-octahydro-7bH-cyclopenta-[b][1,4]diazepino[6,7,1hi]indole]: A novel 5-hydroxytryptamine 2C receptor-selective agonist with preclinical antipsychotic-like activity.
    Marquis KL; Sabb AL; Logue SF; Brennan JA; Piesla MJ; Comery TA; Grauer SM; Ashby CR; Nguyen HQ; Dawson LA; Barrett JE; Stack G; Meltzer HY; Harrison BL; Rosenzweig-Lipson S
    J Pharmacol Exp Ther; 2007 Jan; 320(1):486-96. PubMed ID: 17038512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of 5-HT
    Maxwell J; Gleason SD; Falcone J; Svensson K; Balcer OM; Li X; Witkin JM
    Behav Brain Res; 2019 Feb; 359():467-473. PubMed ID: 30471311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Habituation deficits induced by metabotropic glutamate receptors 2/3 receptor blockade in mice: reversal by antipsychotic drugs.
    Bespalov A; Jongen-Rêlo AL; van Gaalen M; Harich S; Schoemaker H; Gross G
    J Pharmacol Exp Ther; 2007 Feb; 320(2):944-50. PubMed ID: 17135347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antipsychotic property of a muscarinic receptor agonist in animal models for schizophrenia.
    Maehara S; Hikichi H; Satow A; Okuda S; Ohta H
    Pharmacol Biochem Behav; 2008 Nov; 91(1):140-9. PubMed ID: 18651995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic knockout and pharmacological blockade studies of the 5-HT7 receptor suggest therapeutic potential in depression.
    Guscott M; Bristow LJ; Hadingham K; Rosahl TW; Beer MS; Stanton JA; Bromidge F; Owens AP; Huscroft I; Myers J; Rupniak NM; Patel S; Whiting PJ; Hutson PH; Fone KC; Biello SM; Kulagowski JJ; McAllister G
    Neuropharmacology; 2005 Mar; 48(4):492-502. PubMed ID: 15755477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of antipsychotic and relative drugs using disruption of prepulse inhibition as an animal model for schizophrenia].
    Suemaru K; Kohnomi S; Umeda K; Araki H
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2008 Jun; 28(3):121-6. PubMed ID: 18646597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The neurotensin agonist NT69L improves sensorimotor gating deficits in rats induced by a glutamatergic antagonist, but not by dopaminergic agonists.
    Secchi RL; Sung E; Hedley LR; Button D; Schreiber R
    Behav Brain Res; 2009 Sep; 202(2):192-7. PubMed ID: 19463701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inactivation of the 5-HT(7) receptor partially blocks phencyclidine-induced disruption of prepulse inhibition.
    Semenova S; Geyer MA; Sutcliffe JG; Markou A; Hedlund PB
    Biol Psychiatry; 2008 Jan; 63(1):98-105. PubMed ID: 17531208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strain-specific effects of amphetamine on prepulse inhibition and patterns of locomotor behavior in mice.
    Ralph RJ; Paulus MP; Geyer MA
    J Pharmacol Exp Ther; 2001 Jul; 298(1):148-55. PubMed ID: 11408536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of 5-HT7 receptor antagonism in the amelioration of MK-801-induced learning and memory deficits by the novel atypical antipsychotic drug lurasidone.
    Horisawa T; Nishikawa H; Toma S; Ikeda A; Horiguchi M; Ono M; Ishiyama T; Taiji M
    Behav Brain Res; 2013 May; 244():66-9. PubMed ID: 23376699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the mGlu8 receptor as a putative therapeutic target in schizophrenia.
    Robbins MJ; Starr KR; Honey A; Soffin EM; Rourke C; Jones GA; Kelly FM; Strum J; Melarange RA; Harris AJ; Rocheville M; Rupniak T; Murdock PR; Jones DN; Kew JN; Maycox PR
    Brain Res; 2007 Jun; 1152():215-27. PubMed ID: 17434465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.